This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Christopher H. Bachran: Innovator in Cancer Treatment
Introduction
Christopher H. Bachran is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of innovative methods for cancer treatment. His work focuses on the use of proteins and chimeric molecules to combat cancerous cells.
Latest Patents
Christopher H. Bachran holds a patent that discloses a protein comprising a cytolethal distending toxin subunit B (CdtB) conjugated or fused to a lethal factor (LF) or a functional portion of LF. This patent also includes related chimeric molecules, nucleic acids, recombinant expression vectors, host cells, populations of cells, pharmaceutical compositions, and methods for treating or preventing cancer. The innovative approach aims to inhibit the growth of target cells effectively.
Career Highlights
Bachran's career is marked by his association with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work has been instrumental in advancing the understanding of cancer therapies and the development of new treatment methodologies.
Collaborations
One of his notable collaborators is Stephen H. Leppla, with whom he has worked on various projects related to his patent and cancer research.
Conclusion
Christopher H. Bachran's contributions to cancer treatment through innovative protein technologies highlight his role as a leading inventor in the field. His work continues to pave the way for new therapeutic strategies against cancer.